Department of Medical Microbiology, Ege University Medical Faculty of Medicine, Bornova, Turkey.
Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2133-2143. doi: 10.1007/s10096-019-03654-4. Epub 2019 Sep 7.
There are several approaches available for purifying microorganisms prior to matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis. In the present study, rapid BACpro® II (Nittobo Medical Co., Ltd., Tokyo, Japan), a new application, has been compared with Sepsityper® kit (Bruker Daltonics, Billerica, USA) and an in-house method. Samples were also tested with two modules, standard and Sepsityper®, identified in the Bruker MALDI-TOF MS. The bottles having monomicrobial growth were included in the study according to Gram staining results. In total, two hundred blood culture bottles were included but there was no growth in one of the subcultures so 199 blood culture bottles were studied prospectively. With the standard MALDI-TOF MS analysis, rapid BACpro® II could successfully identify microorganisms in 174/199 (87.4%) of the bottles where Sepsityper® kit and in-house method were successful in 136/199 (68.3%) and 114/199 (57.3%), respectively. When the MALDI-TOF MS data were analysed by Sepsityper® module, the identification rates were increased to 94.4%, 82.1% and 69.8% (p < 0.001), respectively. In the Sepsityper® module, 72/73 (98.6%) of Gram-negative and 97/106 (91.5%) of Gram-positive microorganisms were detected by rapid BACpro® II method. The present study shows that rapid BACpro® II is a reliable preparation procedure and has higher rates of identification compared with Sepsityper® kit and in-house method. The use of the Sepsityper® module in blood cultures increases the chance of identification for all three methods studied.
在进行基质辅助激光解吸电离飞行时间质谱分析(MALDI-TOF MS)之前,有几种方法可用于纯化微生物。在本研究中,快速 BACpro® II(日本日东电工株式会社),一种新的应用,与 Sepsityper®试剂盒(布鲁克道尔顿公司,美国比勒陀利亚)和内部方法进行了比较。样品还使用两种模块,标准模块和 Sepsityper®模块,进行了 Bruker MALDI-TOF MS 鉴定。根据革兰氏染色结果,将单种微生物生长的瓶纳入研究范围。总共有 200 个血培养瓶被纳入研究,但其中一个亚培养物没有生长,因此前瞻性地研究了 199 个血培养瓶。使用标准 MALDI-TOF MS 分析,快速 BACpro® II 能够成功鉴定 199 个瓶中的 174 个(87.4%),Sepsityper®试剂盒和内部方法成功鉴定了 136/199(68.3%)和 114/199(57.3%)。当 MALDI-TOF MS 数据通过 Sepsityper®模块进行分析时,鉴定率分别提高到 94.4%、82.1%和 69.8%(p < 0.001)。在 Sepsityper®模块中,快速 BACpro® II 方法能够检测到 72/73(98.6%)种革兰氏阴性菌和 97/106(91.5%)种革兰氏阳性菌。本研究表明,快速 BACpro® II 是一种可靠的制备程序,与 Sepsityper®试剂盒和内部方法相比,具有更高的鉴定率。三种方法都使用 Sepsityper®模块可以增加鉴定的机会。